AbbVie, Merck Offer Stable Dividends Amid Market Volatility

Investors seeking stability in August are turning to two pharmaceutical stocks that offer solid dividends and resilient business models, according to a recent Motley Fool analysis. The article highlights AbbVie and Merck as the most attractive options, citing their strong cash flows and robust product pipelines amid market volatility.

The backdrop for this recommendation is a turbulent equity market, marked by geopolitical tensions, inflationary pressures, and uncertainty about a potential bear cycle. In such an environment, dividend‑paying companies are viewed as safer bets because they can provide regular income even when share prices swing. Both AbbVie and Merck have long histories of raising dividends each year, a trait that appeals to risk‑averse investors looking for income and downside protection.

AbbVie’s appeal lies in its core drug portfolio and its ability to weather patent expirations. After the loss of exclusivity for its flagship product Humira, the company successfully shifted focus to immunology drugs Skyrizi and Rinvoq, which are already outperforming expectations. AbbVie’s earnings grew 10 % year over year in the second quarter, with adjusted earnings per share climbing 23 % to $3.65. The firm’s dividend program, classified as a “Dividend King” because it has increased payouts for more than 50 consecutive years, underscores its commitment to returning cash to shareholders. Looking ahead, AbbVie is investing in a pipeline that includes a monthly weight‑loss medicine, ABBV‑295, which could provide a new revenue stream when current drugs face competition.

Merck, the other highlighted stock, shares similar strengths. It has a diversified portfolio of pharmaceuticals and vaccines, and it too has a history of consistent dividend growth. The company’s research pipeline includes promising immunotherapies and oncology treatments that could sustain long‑term growth. By combining steady cash flow with a forward‑looking pipeline, Merck offers investors a blend of income and upside potential. As markets remain unpredictable, these dividend leaders provide a buffer against volatility, making them sensible additions to portfolios that prioritize stability and regular returns.